Clinical Trial Update: Maraviroc (Celsentri) With Raltegravir and Darunavir/Ritonavir for the Treatment of Triple Class Failure in Adult HIV-1 Infected Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating maraviroc in combination with raltegravir and darunavir/ritonavir for adults with HIV-1 who have triple-class antiretrovi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Celsentri (maraviroc)
• Isentress (Raltegravir)
• Norvir (ritonavir)
• PREZISTA (darunavir)

Snippet

Sponsor: Fundación Huésped | Conditions: HIV-1 Adults Patients, AIDS | Phase 4 | Status: UNKNOWN